Navigation Links
Using big data to identify prostate cancers and best treatments
Date:5/23/2013

Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease. Researchers at Case Western Reserve University and Johns Hopkins Medical Institutes are developing technology that allows patients to safely choose to do nothing, opt for relatively mild treatments or take drastic measures.

The project is one of several Anant Madabhushi, an associate professor of biomedical engineering at Case Western Reserve and director of the Center for Computational Imaging and Personalized Diagnostics, is involved in.

Madabhushi brought the center and a dozen researchers to Case Western Reserve from Rutgers University this academic year. The center's overall mission is to develop the new science of using big data to identify different forms of diseases and the most effective treatments.

"The data does exist," Madabhushi said. "If someone has a disease, we can detect it. The issue is what to do next. We're detecting half-a-million cases of breast and prostate cancers each year. How do you treat them? What are the options? What is the right treatment?"

Madabhushi and Robert Veltri, an associate professor of urology at Johns Hopkins, have won a three-year, $1.2 million Department of Defense grant to develop a guide to steer prostate cancer patients to the most effective treatment.

The medical community estimates 241,740 prostate cancer cases were diagnosed nationally last year, and the number is expected to grow annually as the population ages and detection improves.

The researchers are concentrating on identifying the 15 percent of prostate cancers considered very low-risk. Sufferers are likely to survive 20 years, depending on the treatment they receive.

"We don't want to expose someone to a therapy that won't work for him," Madabhushi said.

Not only may patients suffer unnecessarily,
'/>"/>

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Stanford engineers monitor heart health using paper-thin flexible skin
2. Bird flu in live poultry markets are the source of viruses causing human infections
3. Mutation causing wrong-way plumbing explains 1 type of blue-baby syndrome
4. Using bacteria-eaters to prevent infections on medical implant materials
5. Neiker-Tecnalia and FARMARABA produce Omega 3 using marine plant micro-organisms
6. Source identification of H7N9 influenza virus causing human infections
7. Virtual, squishy creatures evolve to run using evolutionary algorithms
8. Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk
9. Metabolic fingerprinting: Using proteomics to identify proteins in gymnosperm pollination drops
10. Symbiotic bacteria program daily rhythms in squid using light and chemicals
11. Researchers discover brain cancer treatment using genetic material from bone marrow cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry news, ... website design. "When we launched FindBiometrics 12 years ... O,Neill , founder and CEO of FindBiometrics. "Now it,s maturing ... the key players on a very broad scale.  We are ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... 22, 2015 , Europe,s ... The European Patent Office to present a video retrospective of ... to be featured: Christofer Toumazou and Sophie Wilson ... and winners of the Award   Starting on 22 ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... the California Institute of Technology (Caltech) pioneered the ... immune system and neurodevelopmental disorders such as autism ... brains and of individuals with autism, as well ... alterations in the immune system and autism spectrum ...
... 17, 2012 Toronto Scientists have discovered two ... occurring in nearly half the patients treated with antipsychotic ... Addiction and Mental Health (CAMH). These results ... the variations, enabling clinicians to choose strategies to prevent ...
... have learnt not to use their calls at the same ... at the Polytechnic University of Catalonia have used this form ... to network nodes an operation that can be applied ... be coloured with the least possible number of colours without ...
Cached Biology News:Caltech researchers find evidence of link between immune irregularities and autism 2Caltech researchers find evidence of link between immune irregularities and autism 3Genetic link to rapid weight gain from antipsychotics discovered 2Genetic link to rapid weight gain from antipsychotics discovered 3Frog calls inspire a new algorithm for wireless networks 2
(Date:2/27/2015)... Nova Scotia (PRWEB) February 27, 2015 ... stage vaccine and immunotherapy company, today announced that ... its application for Fast Track designation and Phase ... vaccines, in conjunction with the mutual co-development agreement ... previously obtained Fast Track designation for the DPX-Survivac. ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... LEXINGTON, Mass., Feb. 26, 2015   Synageva ... a biopharmaceutical company developing therapeutic products for rare ... and provided 2015 goals, other key objectives, and ... conference call today at 4:30 p.m. EST to ... business update.  To participate in today,s call by ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... Cato Research Ltd., a global,contract research and development organization, ... new President., Mr. Cline comes to Cato Research ... recently served as President and CEO. Mr. Cline has ... sales,and marketing roles at Organon Inc., Caremark, a division ...
... ANDS ) announced today that it will present ... Tuesday, March 18, 2008 at,3:10 p.m. EDT (12:10 p.m. ... Copley Place., Steve Worland, Ph.D., President and Chief ... of Anadys and its two,development-stage product candidates, ANA598 and ...
... March 11 Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ... Cowen and Company 28th Annual Health Care Conference ... Interested parties may access a live,webcast of the ... that listeners log on 15 minutes early in ...
Cached Biology Technology:Cato Research Names John Cline as President 2Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference 2
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Anti-Human alpha2-Antiplasmin Purified (Polyclonal) (goat IgG)...
Volume adapter mounts on top of the 96 well FiltrEX filter plate and allows larger volumes (1mL) to be applied to each well in a filter plate. Adapters are nonsterile....
... The Mini-PROTEAN 3 Dodeca cell with multi-casting chamber ... up to 12 mini format handcast (8.3 x ... gels. The cell requires 3.4-4.4 L of buffer ... coil that attaches to an external refrigerated circulator ...
Biology Products: